Literature DB >> 7542749

Autoradiographic distribution of [3H]L-NG-nitro-arginine binding in rat brain.

E J Kidd1, A D Michel, P P Humphrey.   

Abstract

The distribution of nitric oxide synthase (NOS), the enzyme which produces nitric oxide, has previously been studied in the rat central nervous system (CNS) using the NADPH-diaphorase technique and anti-NOS antibodies. However, the former method may not always be selective for NOS while the latter is not quantitative. Therefore a selective, quantifiable method would be desirable. L-NG-Nitro-arginine, an inhibitor of NOS, is available in a tritiated form which we have shown to bind to NOS. We have now examined the regional distribution of [3H]L-NG-nitro-arginine binding in the rat CNS using autoradiography. [3H]L-NG-nitro-arginine specific binding was seen in a number of brain regions with the highest levels in the accessory olfactory bulb, the amygdaloid complex, the Islands of Calleja and the cerebellum. This regional distribution of [3H]L-NG-nitro-arginine binding sites in the rat CNS was, in general, similar to that seen with the NADPH-diaphorase method and anti-NOS antibodies, consistent with the view that all three methods identify NOS in the CNS. Thus, [3H]L-NG-nitro-arginine appears to be a useful radioligand for studying the distribution of NOS in the CNS as its binding is quantifiable and apparently selective for NOS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542749     DOI: 10.1016/0028-3908(94)00132-c

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

1.  Regional distribution of binding sites for the nitric oxide synthase inhibitor L-[3H]nitroarginine in rat brain.

Authors:  V L Rao; R F Butterworth
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

2.  Upregulation of (+)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin binding following intracerebroventricular administration of a nitric oxide generator.

Authors:  D R Wallace; R M Booze
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

3.  Effect of nitric oxide synthase inhibitor on age-related changes in second messenger systems and calcium channels in rats.

Authors:  T Araki; H Kato; K Shuto; T Fujiwara; Y Itoyama
Journal:  Metab Brain Dis       Date:  1997-03       Impact factor: 3.584

4.  Evidence for mediation of L-2-chloropropionic acid-induced delayed neuronal cell death by activation of a constitutive nitric oxide synthase.

Authors:  P S Widdowson; M Farnworth; R B Moore; D Dunn; I Wyatt
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

5.  Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies.

Authors:  R A Rutherford; A McCarthy; M H Sullivan; M G Elder; J M Polak; J Wharton
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

6.  Nitric oxide synthase is expressed in experimental malignant glioma and influences tumour blood flow.

Authors:  I R Whittle; F Collins; P A Kelly; I Ritchie; J W Ironside
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

7.  Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum.

Authors:  C Frisch; E Dere; M A Silva; A Godecke; J Schrader; J P Huston
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

8.  Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.

Authors:  Y Muramatsu; R Kurosaki; T Mikami; M Michimata; M Matsubara; Y Imai; H Kato; Y Itoyama; T Araki
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

9.  Brain BDNF levels elevation induced by physical training is reduced after unilateral common carotid artery occlusion in rats.

Authors:  Hayat Banoujaafar; Jacques Van Hoecke; Claude M Mossiat; Christine Marie
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-23       Impact factor: 6.200

Review 10.  Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges.

Authors:  Jan Víteček; Antonín Lojek; Giuseppe Valacchi; Lukáš Kubala
Journal:  Mediators Inflamm       Date:  2012-09-04       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.